Adrian G. Bateman

GlaxoSmithKline (United Kingdom)

Papers

1

Total Citations

15

H-Index

1

About

Adrian G. Bateman is a pharmaceutical scientist recognized for his contributions to the development of automated methodologies for drug stability testing. His key research area centers on the forced degradation of active pharmaceutical ingredients (APIs), a critical process in understanding drug stability and degradation pathways. Bateman’s most notable work, "An automated workstation for forced degradation of active pharmaceutical ingredients" (2002), introduced a high-throughput, automated system that significantly improved the efficiency and reproducibility of stress testing in pharmaceutical development. This innovation has been cited 15 times, reflecting its practical impact on streamlining quality control and regulatory compliance in the industry. By automating a traditionally manual and time-consuming process, Bateman’s work has helped accelerate drug development timelines and enhance data reliability. His contributions are particularly valuable for researchers and students in pharmaceutical sciences, analytical chemistry, and drug formulation, offering a foundational approach to modern stability testing. Bateman’s achievement underscores the importance of automation in advancing pharmaceutical research and ensuring the safety and efficacy of new drugs.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
An automated workstation for forced degradation of active pharmaceutical ingredients
15 citations · 2002
📈 Most Prolific Year: 2002 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: GlaxoSmithKline (United Kingdom)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago